A detailed history of Wells Fargo & Company transactions in Veru Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 55,082 shares of VERU stock, worth $39,108. This represents 0.0% of its overall portfolio holdings.

Number of Shares
55,082
Previous 57,200 3.7%
Holding current value
$39,108
Previous $48,000 12.5%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$0.77 - $1.04 $1,630 - $2,202
-2,118 Reduced 3.7%
55,082 $42,000
Q2 2024

Aug 13, 2024

BUY
$0.76 - $1.79 $36,267 - $85,420
47,721 Added 503.44%
57,200 $48,000
Q1 2024

May 10, 2024

BUY
$0.37 - $0.72 $163 - $318
443 Added 4.9%
9,479 $6,000
Q4 2023

Feb 09, 2024

SELL
$0.67 - $1.17 $2,374 - $4,146
-3,544 Reduced 28.17%
9,036 $6,000
Q3 2023

Nov 13, 2023

BUY
$0.72 - $1.33 $192 - $356
268 Added 2.18%
12,580 $9,000
Q2 2023

Aug 15, 2023

SELL
$0.98 - $1.49 $14,260 - $21,682
-14,552 Reduced 54.17%
12,312 $14,000
Q1 2023

May 12, 2023

BUY
$1.16 - $6.41 $14,423 - $79,701
12,434 Added 86.17%
26,864 $31,000
Q4 2022

Feb 13, 2023

SELL
$4.78 - $15.01 $6,218 - $19,528
-1,301 Reduced 8.27%
14,430 $76,000
Q3 2022

Nov 14, 2022

BUY
$10.22 - $23.7 $18,365 - $42,588
1,797 Added 12.9%
15,731 $182,000
Q2 2022

Aug 12, 2022

SELL
$4.35 - $15.85 $51,229 - $186,665
-11,777 Reduced 45.81%
13,934 $158,000
Q1 2022

May 16, 2022

SELL
$4.55 - $6.41 $89,343 - $125,866
-19,636 Reduced 43.3%
25,711 $124,000
Q4 2021

Feb 14, 2022

BUY
$5.89 - $9.73 $235,287 - $388,684
39,947 Added 739.76%
45,347 $268,000
Q3 2021

Nov 15, 2021

SELL
$6.78 - $9.89 $5,898 - $8,604
-870 Reduced 13.88%
5,400 $46,000
Q2 2021

Aug 16, 2021

SELL
$7.24 - $11.2 $106,080 - $164,102
-14,652 Reduced 70.03%
6,270 $51,000
Q1 2021

May 13, 2021

SELL
$8.05 - $20.78 $885,999 - $2.29 Million
-110,062 Reduced 84.03%
20,922 $225,000
Q4 2020

Feb 09, 2021

SELL
$2.36 - $9.99 $63,691 - $269,610
-26,988 Reduced 17.08%
130,984 $1.13 Million
Q3 2020

Nov 05, 2020

SELL
$2.58 - $3.36 $21,953 - $28,590
-8,509 Reduced 5.11%
157,972 $414,000
Q2 2020

Aug 13, 2020

BUY
$3.01 - $4.02 $113,224 - $151,216
37,616 Added 29.19%
166,481 $556,000
Q1 2020

May 14, 2020

BUY
$2.58 - $4.58 $332,471 - $590,201
128,865 New
128,865 $422,000

Others Institutions Holding VERU

About VERU INC.


  • Ticker VERU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 80,146,704
  • Market Cap $56.9M
  • Description
  • Veru Inc., an oncology biopharmaceutical company, focuses on developing medicines for the management of cancers. Its commercial products comprise FC2 female condom/internal condom for the dual protection against unintended pregnancy and the transmission of sexually transmitted infections for ministries of health, government health agencies, U.N....
More about VERU
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.